Updated August 11, 2026 · AltIndex alt-data view going into the print
AltIndex AI Score on Intellia Therapeutics is 36 — signals lean bearish heading into the print. Underlying trend: 7 tracked signals showing mixed direction over the last 3 months.
Intellia Therapeutics (NTLA) is trading at $12.02, down 15.8% over the last 3 months (from $14.28 three months ago).
Trends across the last 3 months — the run-up to Intellia Therapeutics’s next earnings print.
| Signal | Current | 3-month change |
|---|---|---|
| Job postings | 64 | ↑ +82.9% |
| LinkedIn headcount | 506 | ↑ +9.3% |
| Sentiment | 67% Bullish | ↓ -17pp |
| Web traffic | 37,473 | ↓ -34.4% |
| Employee business outlook | 33% Negative | → flat |
| Instagram followers | 1,429 | → +2.7% |
| X followers | 12,208 | → +0.4% |
Full daily-resolution trend charts on every signal are on the NTLA ticker page.
AltIndex stock alerts fire when alt-data on NTLA breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.
Sign up to AltIndex →Other companies in the AltIndex universe reporting earnings in the next 2 weeks, sorted by AI Score.
Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Intellia Therapeutics — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.
Sign up to AltIndex → Log in